Stay updated on Pembrolizumab Combo vs Alone in Stage III Melanoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combo vs Alone in Stage III Melanoma Clinical Trial page.
Latest updates to the Pembrolizumab Combo vs Alone in Stage III Melanoma Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedLocation sections were updated with new site listings across the United States and international regions. Previous location sections were removed and the page revision updated to v3.3.3.SummaryDifference2%
- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check33 days agoChange DetectedRevision: v3.3.2 was added and Revision: v3.3.1 was removed, representing a minor site maintenance update that does not affect study information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%
- Check40 days agoChange DetectedRelated topics Melanoma and MedlinePlus Genetics were added and the publication note was revised. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%
- Check47 days agoChange DetectedThe page no longer displays the site-wide funding status notice and removes Melanoma-related topics and MedlinePlus Genetics from the related topics section. These removals do not modify the study's core content, such as eligibility criteria, endpoints, or contacts. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%
- Check61 days agoChange DetectedNew metadata entries were added (Melanoma; MedlinePlus Genetics) and related topic tags, with associated dates updated (2025-09-24, 2025-10-23, 2025-10-27). Several older date markers were removed (2025-10-06, 2025-10-14, 2025-10-16).SummaryDifference0.7%
- Check68 days agoChange Detected- Melanoma and MedlinePlus Genetics were removed from the page's related topics. - This reduces visibility of melanoma-related information on the study page.SummaryDifference0.1%
Stay in the know with updates to Pembrolizumab Combo vs Alone in Stage III Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo vs Alone in Stage III Melanoma Clinical Trial page.